These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26168911)

  • 1. Therapy: Secukinumab improves symptoms of psoriatic arthritis.
    Duarte JH
    Nat Rev Rheumatol; 2015 Sep; 11(9):503. PubMed ID: 26168911
    [No Abstract]   [Full Text] [Related]  

  • 2. Secukinumab and psoriatic arthritis.
    Prescrire Int; 2017 Mar; 26(180):62. PubMed ID: 30730617
    [No Abstract]   [Full Text] [Related]  

  • 3. Secukinumab Use in Psoriatic Arthritis.
    Jagdish RK; Shailly ; Bhatnagar MK
    J Assoc Physicians India; 2018 Dec; 66(12):78. PubMed ID: 31315331
    [No Abstract]   [Full Text] [Related]  

  • 4. Secukinumab: A Review in Psoriatic Arthritis.
    Shirley M; Scott LJ
    Drugs; 2016 Jul; 76(11):1135-45. PubMed ID: 27299434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond anti-TNF-α agents in psoriatic arthritis.
    Spadaro A; Lubrano E
    Expert Rev Clin Immunol; 2013 Jun; 9(6):507-9. PubMed ID: 23730881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study.
    Kavanaugh A; McInnes IB; Mease PJ; Hall S; Chinoy H; Kivitz AJ; Wang Z; Mpofu S
    J Rheumatol; 2016 Sep; 43(9):1713-7. PubMed ID: 27307536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-17 inhibition in psoriatic arthritis.
    Helliwell P; Coates L
    Lancet; 2015 Sep; 386(9999):1114-6. PubMed ID: 26135705
    [No Abstract]   [Full Text] [Related]  

  • 8. Paradoxical localized exacerbation of psoriatic eruptions triggered by secukinumab.
    Hoshina D; Haga N; Furuya K; Sakai M
    Clin Exp Dermatol; 2018 Aug; 43(6):718-719. PubMed ID: 29314197
    [No Abstract]   [Full Text] [Related]  

  • 9. [The therapeutic benefits of systemic treatment of psoriatic arthritis? The example of golimumab in psoriatic arthritis].
    Boulinguez S; Sibilia J
    Ann Dermatol Venereol; 2011 May; 138(5 Suppl 1):H11-5. PubMed ID: 21703459
    [No Abstract]   [Full Text] [Related]  

  • 10. Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study.
    McInnes IB; Mease PJ; Ritchlin CT; Rahman P; Gottlieb AB; Kirkham B; Kajekar R; Delicha EM; Pricop L; Mpofu S
    Rheumatology (Oxford); 2017 Nov; 56(11):1993-2003. PubMed ID: 28968735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healing of psoriatic skin lesions, and improvement of psoriatic arthritis resistant to immunosuppressive drugs, after infliximab treatment.
    Nikas SN; Voulgari PV; Takalou IP; Katsimbri P; Drosos AA
    Ann Rheum Dis; 2005 Nov; 64(11):1665-7. PubMed ID: 16227426
    [No Abstract]   [Full Text] [Related]  

  • 12. Long term treatment of psoriatic arthritis with infliximab.
    Yazdani-Biuki B; Wohlfahrt K; Mulabecirovic A; Mueller T; Hermann J; Graninger WB; Brezinschek HP; Brezinschek RI
    Ann Rheum Dis; 2004 Nov; 63(11):1531-2; author reply 1532. PubMed ID: 15479917
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adalimumab in arthritis psoriatica].
    Szekanecz Z
    Orv Hetil; 2009 Jul; 150(30):1423. PubMed ID: 19592338
    [No Abstract]   [Full Text] [Related]  

  • 14. Is there a need for new agents with novel mechanisms of action in psoriatic arthritis?
    Orr C; Veale DJ
    Ann Rheum Dis; 2014 Jun; 73(6):951-3. PubMed ID: 24790066
    [No Abstract]   [Full Text] [Related]  

  • 15. Long term infliximab treatment for severe psoriatic arthritis: evidence of sustained clinical and radiographic response.
    Rinaldi F; Provenzano G; Termini A; Spinello M; La Seta F
    Ann Rheum Dis; 2005 Sep; 64(9):1375-6. PubMed ID: 16100346
    [No Abstract]   [Full Text] [Related]  

  • 16. Psoriatic arthritis patients doing better on infliximab than etanercept.
    Smith N; Gadsby K; Deighton C
    Rheumatology (Oxford); 2007 Apr; 46(4):721-2. PubMed ID: 17314216
    [No Abstract]   [Full Text] [Related]  

  • 17. Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
    Rossini M; Viapiana O; Orsolini G; Fracassi E; Idolazzi L; Gatti D; Adami S; Govoni M
    Reumatismo; 2015 Mar; 66(4):285-303. PubMed ID: 25829189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriatic arthritis.
    Durham LE; Taams LS; Kirkham BW
    Br J Hosp Med (Lond); 2016 Jul; 77(7):C102-8. PubMed ID: 27388392
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of infliximab for the treatment of psoriatic arthritis.
    Ritchlin C
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):300-1. PubMed ID: 16932707
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of different outcome measures for psoriatic arthritis in patients treated with infliximab or placebo.
    Vander Cruyssen B; De Keyser F; Kruithof E; Mielants H; Van den Bosch F
    Ann Rheum Dis; 2007 Jan; 66(1):138-40. PubMed ID: 17178763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.